1.Farber HW., Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004. 351:1655–65.
Article
2.Machado RD., Eickelberg O., Elliott CG., Geraci MW., Hanaoka M., Loyd JE, et al. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol. 2009. 54:S32–42.
Article
3.Machado RD., Southgate L., Eichstaedt CA., Aldred MA., Austin ED., Best DH, et al. Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects. Hum Mutat. 2015. 36:1113–27.
Article
4.Leter EM., Boonstra AB., Postma FB., Gille JJ., Meijers-Heijboer EJ., Vonk Noordegraaf A. Genetic counselling for pulmonary arterial hypertension: a matter of variable variability. Neth Heart J. 2011. 19:89–92.
Article
5.McLaughlin VV., McGoon MD. Pulmonary arterial hypertension. Circulation. 2006. 114:1417–31.
Article
6.Rosenzweig EB., Morse JH., Knowles JA., Chada KK., Khan AM., Roberts KE, et al. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension. J Heart Lung Transplant. 2008. 27:668–74.
Article
7.Cooper DN., Ball EV., Stenson PD., Phillips AD., Evans K., Heywood S, et al. The human gene mutation database. http://www.hgmd.cf.ac.uk/ac/gene.php?gene=BMPR2. (updated on Feb 2017).
8.Austin ED., Loyd JE. Heritable forms of pulmonary arterial hypertension. Semin Respir Crit Care Med. 2013. 34:568–80.
Article
9.Griffths AJF., Miller JH., Suzuki DT., Lewontin RC., Gelbart WM. An introduction to genetic analysis. 7th ed.https://www.ncbi.nlm.nih.gov/books/NBK22090. (Updated on 2000).
10.Machado RD., Pauciulo MW., Thomson JR., Lane KB., Morgan NV., Wheeler L, et al. BMPR2 haploinsuffciency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Human Genet. 2001. 68:92–102.
11.Hoeper MM., Huscher D., Ghofrani HA., Delcroix M., Distler O., Schwei-ger C, et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol. 2013. 168:871–80.
Article
12.Loyd JE., Butler MG., Foroud TM., Conneally PM., Phillips JA 3rd., Newman JH. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med. 1995. 152:93–7.
Article
13.Machado RD., James V., Southwood M., Harrison RE., Atkinson C., Stewart S, et al. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension. Circulation. 2005. 111:607–13.
14.Chelladurai P., Seeger W., Pullamsetti SS. Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives. Eur Respir Rev. 2016. 25:135–40.
Article
15.Sztrymf B., Yaïci A., Girerd B., Humbert M. Genes and pulmonary arterial hypertension. Respiration. 2007. 74:123–32.
Article
16.Galie N., Humbert M., Vachiery JL., Gibbs S., Lang I., Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016. 37:67–119.